Cherrington Julie M

Director at HIGHLAND BUSINESS SERVICES, INC. · on record since Mar 4, 2024
Director at Mirati Therapeutics, Inc. · on record since Jul 1, 2019
Director at NABI BIOPHARMACEUTICALS · on record since Aug 23, 2021

Insider trading activity of Cherrington Julie M

Transactions on record: 26; since Jul 1, 2019

Open-market buys: 0

Open-market sells: 4; $686.9K

Companies traded: 3; last filing Jul 24, 2025

Figures computed from official regulatory filings — methodology.

Companies where Cherrington Julie M has traded

HIGHLAND BUSINESS SERVICES, INC.6 tx · Jul 24, 2025
Mirati Therapeutics, Inc.17 tx · $1.1M · Jan 23, 2024
NABI BIOPHARMACEUTICALS3 tx · Aug 8, 2022

Track record of Cherrington Julie M

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Cherrington Julie M

Co-insiders of Cherrington Julie M

Sandler Alan B.HIGHLAND BUSINESS SERVICES, INC. +1
4Ward Enterprise, Inc.HIGHLAND BUSINESS SERVICES, INC.
667, L.P.Mirati Therapeutics, Inc.
Adelman Robert JHIGHLAND BUSINESS SERVICES, INC.
Aghazadeh BehzadMirati Therapeutics, Inc.
Ahmad FuadNABI BIOPHARMACEUTICALS
Aisling Capital IV, LPHIGHLAND BUSINESS SERVICES, INC.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
HIGHLAND BUSINESS SERVICES, INC.	Jul 24, 2025	OtherD	-55,000	0.00 USD	$0	SEC
HIGHLAND BUSINESS SERVICES, INC.	Jul 24, 2025	OtherD	-35,000	0.00 USD	$0	SEC
HIGHLAND BUSINESS SERVICES, INC.	Jul 24, 2025	OtherD	-35,000	0.00 USD	$0	SEC
HIGHLAND BUSINESS SERVICES, INC.	Jun 9, 2025	AwardD	35,000	0.00 USD	$0	SEC
HIGHLAND BUSINESS SERVICES, INC.	Jun 17, 2024	AwardD	35,000	0.00 USD	$0	SEC
HIGHLAND BUSINESS SERVICES, INC.	Mar 4, 2024	AwardD	55,000	0.00 USD	$0	SEC
Mirati Therapeutics, Inc.	Jan 23, 2024	Other	-6,808	—	—	SEC
Mirati Therapeutics, Inc.	Jan 23, 2024	Other	-4,444	—	—	SEC
Mirati Therapeutics, Inc.	Jan 23, 2024	OtherD	-7,520	—	—	SEC
Mirati Therapeutics, Inc.	Jan 3, 2024	Award	6,808	58.75 USD	$400K	SEC
Mirati Therapeutics, Inc.	Jan 24, 2023	Award	4,444	0.00 USD	$0	SEC
Mirati Therapeutics, Inc.	Jan 24, 2023	AwardD	7,520	0.00 USD	$0	SEC
Mirati Therapeutics, Inc.	Jan 20, 2023	Sell	-2,546	44.66 USD	$113.7K	SEC
NABI BIOPHARMACEUTICALS	Aug 8, 2022	Award	6,217	0.00 USD	$0	SEC
NABI BIOPHARMACEUTICALS	Aug 8, 2022	AwardD	37,280	0.00 USD	$0	SEC
Mirati Therapeutics, Inc.	Jan 20, 2022	Sell	-1,475	116.07 USD	$171.2K	SEC
Mirati Therapeutics, Inc.	Jan 18, 2022	AwardD	3,688	0.00 USD	$0	SEC
Mirati Therapeutics, Inc.	Jan 18, 2022	Award	2,546	0.00 USD	$0	SEC
NABI BIOPHARMACEUTICALS	Aug 23, 2021	AwardD	65,700	0.00 USD	$0	SEC
Mirati Therapeutics, Inc.	Mar 4, 2021	Sell	-10	203.00 USD	$2K	SEC
Mirati Therapeutics, Inc.	Mar 4, 2021	Sell	-1,990	201.00 USD	$400K	SEC
Mirati Therapeutics, Inc.	Jan 20, 2021	Award	1,475	0.00 USD	$0	SEC
Mirati Therapeutics, Inc.	Jan 20, 2021	AwardD	2,155	0.00 USD	$0	SEC
Mirati Therapeutics, Inc.	Jan 7, 2020	AwardD	4,000	0.00 USD	$0	SEC
Mirati Therapeutics, Inc.	Jan 7, 2020	Award	2,000	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
HIGHLAND BUSINESS SERVICES, INC.	Jul 24, 2025	OtherD	-55,000	0.00 USD	$0	SEC
HIGHLAND BUSINESS SERVICES, INC.	Jul 24, 2025	OtherD	-35,000	0.00 USD	$0	SEC
HIGHLAND BUSINESS SERVICES, INC.	Jul 24, 2025	OtherD	-35,000	0.00 USD	$0	SEC
HIGHLAND BUSINESS SERVICES, INC.	Jun 9, 2025	AwardD	35,000	0.00 USD	$0	SEC
HIGHLAND BUSINESS SERVICES, INC.	Jun 17, 2024	AwardD	35,000	0.00 USD	$0	SEC
HIGHLAND BUSINESS SERVICES, INC.	Mar 4, 2024	AwardD	55,000	0.00 USD	$0	SEC
Mirati Therapeutics, Inc.	Jan 23, 2024	Other	-6,808	—	—	SEC
Mirati Therapeutics, Inc.	Jan 23, 2024	Other	-4,444	—	—	SEC
Mirati Therapeutics, Inc.	Jan 23, 2024	OtherD	-7,520	—	—	SEC
Mirati Therapeutics, Inc.	Jan 3, 2024	Award	6,808	58.75 USD	$400K	SEC
Mirati Therapeutics, Inc.	Jan 24, 2023	Award	4,444	0.00 USD	$0	SEC
Mirati Therapeutics, Inc.	Jan 24, 2023	AwardD	7,520	0.00 USD	$0	SEC
Mirati Therapeutics, Inc.	Jan 20, 2023	Sell	-2,546	44.66 USD	$113.7K	SEC
NABI BIOPHARMACEUTICALS	Aug 8, 2022	Award	6,217	0.00 USD	$0	SEC
NABI BIOPHARMACEUTICALS	Aug 8, 2022	AwardD	37,280	0.00 USD	$0	SEC
Mirati Therapeutics, Inc.	Jan 20, 2022	Sell	-1,475	116.07 USD	$171.2K	SEC
Mirati Therapeutics, Inc.	Jan 18, 2022	AwardD	3,688	0.00 USD	$0	SEC
Mirati Therapeutics, Inc.	Jan 18, 2022	Award	2,546	0.00 USD	$0	SEC
NABI BIOPHARMACEUTICALS	Aug 23, 2021	AwardD	65,700	0.00 USD	$0	SEC
Mirati Therapeutics, Inc.	Mar 4, 2021	Sell	-10	203.00 USD	$2K	SEC
Mirati Therapeutics, Inc.	Mar 4, 2021	Sell	-1,990	201.00 USD	$400K	SEC
Mirati Therapeutics, Inc.	Jan 20, 2021	Award	1,475	0.00 USD	$0	SEC
Mirati Therapeutics, Inc.	Jan 20, 2021	AwardD	2,155	0.00 USD	$0	SEC
Mirati Therapeutics, Inc.	Jan 7, 2020	AwardD	4,000	0.00 USD	$0	SEC
Mirati Therapeutics, Inc.	Jan 7, 2020	Award	2,000	0.00 USD	$0	SEC